Published in Circ Res on March 05, 2013
The impact of juvenile coxsackievirus infection on cardiac progenitor cells and postnatal heart development. PLoS Pathog (2014) 1.41
Human stem cells for modeling heart disease and for drug discovery. Sci Transl Med (2014) 1.24
Endothelial cells contribute to generation of adult ventricular myocytes during cardiac homeostasis. Cell Rep (2014) 1.02
PDGFRα demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium. Nat Commun (2015) 0.97
Cardiac stem cell therapy for cardiac repair. Curr Treat Options Cardiovasc Med (2014) 0.96
Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium. Circ Res (2015) 0.95
Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure. Eur Heart J (2016) 0.91
Making it stick: chasing the optimal stem cells for cardiac regeneration. Expert Rev Cardiovasc Ther (2014) 0.91
Stem cell therapy for cardiac dysfunction. Springerplus (2014) 0.90
Origin of cardiomyocytes in the adult heart. Circ Res (2015) 0.89
c-kit-Positive cardiac progenitor cells: the heart of stemness. Circ Res (2013) 0.85
Different types of cultured human adult cardiac progenitor cells have a high degree of transcriptome similarity. J Cell Mol Med (2014) 0.83
The Role of MicroRNAs in Cardiac Stem Cells. Stem Cells Int (2015) 0.83
Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine. Annu Rev Genet (2015) 0.82
Enhanced efficiency of genetic programming toward cardiomyocyte creation through topographical cues. Biomaterials (2015) 0.82
Bone Marrow Is a Reservoir for Cardiac Resident Stem Cells. Sci Rep (2016) 0.82
Cardiac stem cells: biology and clinical applications. Antioxid Redox Signal (2014) 0.80
Predicting the future with stem cells. Circulation (2013) 0.79
Epigenomic Reprogramming of Adult Cardiomyocyte-Derived Cardiac Progenitor Cells. Sci Rep (2015) 0.78
Myocyte renewal and therapeutic myocardial regeneration using various progenitor cells. Heart Fail Rev (2014) 0.77
Developmental origin and lineage plasticity of endogenous cardiac stem cells. Development (2016) 0.77
Radiation Exposure Decreases the Quantity and Quality of Cardiac Stem Cells in Mice. PLoS One (2016) 0.77
Pediatric End-Stage Failing Hearts Demonstrate Increased Cardiac Stem Cells. Ann Thorac Surg (2015) 0.77
Induced pluripotent stem cells for cardiovascular disease: from product-focused disease modeling to process-focused disease discovery. Regen Med (2015) 0.77
Cortical bone-derived stem cells: a novel class of cells for myocardial protection. Circ Res (2013) 0.77
Multipotent stem cells of the heart-do they have therapeutic promise? Front Physiol (2015) 0.76
Expression of dual nucleotides/cysteinyl-leukotrienes receptor GPR17 in early trafficking of cardiac stromal cells after myocardial infarction. J Cell Mol Med (2014) 0.76
Cell models of arrhythmogenic cardiomyopathy: advances and opportunities. Dis Model Mech (2017) 0.75
The Role of Cardiac Side Population Cells in Cardiac Regeneration. Front Cell Dev Biol (2016) 0.75
Improved Method for Isolation of Neonatal Rat Cardiomyocytes with Increased Yield of C-Kit+ Cardiac Progenitor Cells. J Stem Cell Res Ther (2016) 0.75
Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety. Stem Cells Dev (2015) 0.75
Prion Protein and Stage Specific Embryo Antigen 1 as Selection Markers to Enrich the Fraction of Murine Embryonic Stem Cell-Derived Cardiomyocytes. Yonago Acta Med (2016) 0.75
Stem Cell Therapy for the Heart: Blind Alley or Magic Bullet? J Cardiovasc Transl Res (2016) 0.75
Brain derived neurotrophic factor contributes to the cardiogenic potential of adult resident progenitor cells in failing murine heart. PLoS One (2015) 0.75
A Novel Class of Human Cardiac Stem Cells. Cardiol Rev (2015) 0.75
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med (2001) 10.03
Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet (2012) 9.86
Chimerism of the transplanted heart. N Engl J Med (2002) 8.69
Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res (2004) 8.41
Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci (2006) 8.09
Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A (2003) 7.87
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest (2001) 7.20
Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci U S A (2001) 7.19
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 7.14
Mast cells. Physiol Rev (1997) 6.51
Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation (2006) 5.99
Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol (1976) 5.71
Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet (2005) 5.51
Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation (2003) 5.20
Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58
Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest (2006) 4.51
The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood (2002) 4.02
Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci U S A (1997) 3.74
Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science (2000) 3.63
Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem (2003) 3.41
Regenerating functional myocardium: improved performance after skeletal myoblast transplantation. Nat Med (1998) 3.28
Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) (2005) 3.00
Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res (2002) 2.94
Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation (2002) 2.93
Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol (1997) 2.92
Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol (2004) 2.89
The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. Anat Rec A Discov Mol Cell Evol Biol (2004) 2.05
Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol (2007) 2.02
Cardiac muscle plasticity in adult and embryo by heart-derived progenitor cells. Ann N Y Acad Sci (2004) 1.80
Hematopoietic origins of fibroblasts: II. In vitro studies of fibroblasts, CFU-F, and fibrocytes. Exp Hematol (2006) 1.45
Evidence for ischemia induced host-derived bone marrow cell mobilization into cardiac allografts. J Mol Cell Cardiol (2006) 1.41
Nonmuscle myosin II isoform and domain specificity during early mouse development. Proc Natl Acad Sci U S A (2010) 1.16
Secondary sphere formation enhances the functionality of cardiac progenitor cells. Mol Ther (2012) 0.94
Macrophage C-type lectin on bone marrow-derived immature dendritic cells is involved in the internalization of glycosylated antigens. Glycobiology (2002) 0.92
Heart to heart: cardiospheres for myocardial regeneration. Heart Rhythm (2012) 0.91
Immunohistochemical and flow cytometric analysis of long-term label-retaining cells in the adult heart. Stem Cells Dev (2010) 0.89
Hematopoietic stem cell origin of mesenchymal cells: opportunity for novel therapeutic approaches. Int J Hematol (2010) 0.87
Xenopus spinal neurons express Kv2 potassium channel transcripts during embryonic development. J Neurosci (1996) 0.86
Human bone marrow-derived adult stem cells for post-myocardial infarction cardiac repair: current status and future directions. Singapore Med J (2009) 0.82
Expression of LSLCL, a new C-type lectin, is closely restricted, in bone marrow, to immature neutrophils. C R Acad Sci III (2001) 0.81
Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell (2003) 18.09
Concern Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet (2011) 11.45
Chimerism of the transplanted heart. N Engl J Med (2002) 8.69
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Human cardiac stem cells. Proc Natl Acad Sci U S A (2007) 7.76
Perioperative fluid therapy with tetrastarch and gelatin in cardiac surgery--a prospective sequential analysis*. Crit Care Med (2013) 5.88
Evidence for human lung stem cells. N Engl J Med (2011) 5.67
Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58
In vivo visualization of embryonic stem cell survival, proliferation, and migration after cardiac delivery. Circulation (2006) 4.48
A nonviral minicircle vector for deriving human iPS cells. Nat Methods (2010) 4.42
Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor-1 overexpression. Circ Res (2004) 4.13
Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci U S A (2005) 4.13
Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res (2005) 3.93
Myocardial regeneration by activation of multipotent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A (2005) 3.93
Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell (2012) 3.66
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc Natl Acad Sci U S A (2005) 3.64
Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc Natl Acad Sci U S A (2009) 3.57
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med (2012) 3.53
Comparative efficacy, acceptability, and tolerability of augmentation agents in treatment-resistant depression: systematic review and network meta-analysis. J Clin Psychiatry (2015) 3.46
Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation (2010) 3.42
Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res (2004) 3.39
Bipolar disorder. Lancet (2002) 3.26
Implementation of an evidence-based "standard operating procedure" and outcome in septic shock. Crit Care Med (2006) 3.18
Chronic and treatment resistant depression: diagnosis and stepwise therapy. Dtsch Arztebl Int (2014) 3.14
Local activation or implantation of cardiac progenitor cells rescues scarred infarcted myocardium improving cardiac function. Circ Res (2008) 3.07
Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A (2007) 3.06
An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol (2011) 3.05
Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A (2003) 2.95
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res (2004) 2.91
Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One (2010) 2.86
Transcriptional and functional profiling of human embryonic stem cell-derived cardiomyocytes. PLoS One (2008) 2.85
Cardiomyogenesis in the adult human heart. Circ Res (2010) 2.79
Myocyte turnover in the aging human heart. Circ Res (2010) 2.77
Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet (2011) 2.71
Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res (2006) 2.71
Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells. J Clin Invest (2011) 2.69
Clonality of mouse and human cardiomyogenesis in vivo. Proc Natl Acad Sci U S A (2009) 2.60
A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Med (2009) 2.60
Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol (2009) 2.58
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity. Circulation (2013) 2.57
Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation (2006) 2.56
Aging and disease as modifiers of efficacy of cell therapy. Circ Res (2008) 2.51
Survival in critical illness is associated with early activation of mitochondrial biogenesis. Am J Respir Crit Care Med (2010) 2.48
Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res (2003) 2.45
MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev (2009) 2.44
Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res (2009) 2.44
Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med (2007) 2.39
Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation (2011) 2.38
Adolescent feline heart contains a population of small, proliferative ventricular myocytes with immature physiological properties. Circ Res (2007) 2.38
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury. J Clin Invest (2005) 2.36
Short-term immunosuppression promotes engraftment of embryonic and induced pluripotent stem cells. Cell Stem Cell (2011) 2.35
Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. Cell Stem Cell (2013) 2.33
MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation (2010) 2.32
Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res (2008) 2.31
Renal effects of synthetic colloids and crystalloids in patients with severe sepsis: a prospective sequential comparison. Crit Care Med (2011) 2.30
Effects of cell number on teratoma formation by human embryonic stem cells. Cell Cycle (2009) 2.30
Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation (2009) 2.30
Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci U S A (2003) 2.28
Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res (2003) 2.26
Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A (2008) 2.25
Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet (2010) 2.24
The efficacy and safety of colloid resuscitation in the critically ill. Anesth Analg (2010) 2.23
Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A (2009) 2.23
Notch1 regulates the fate of cardiac progenitor cells. Proc Natl Acad Sci U S A (2008) 2.22
Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation (2008) 2.22
Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation (2007) 2.21
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation (2013) 2.19
Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res (2005) 2.18
Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. J Am Coll Cardiol (2012) 2.18
Retracted Cardiomyogenesis in the aging and failing human heart. Circulation (2012) 2.16
Cardiac-specific IGF-1 expression attenuates dilated cardiomyopathy in tropomodulin-overexpressing transgenic mice. Circ Res (2002) 2.11
Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med (2010) 2.08
Patient-specific stem cells and cardiovascular drug discovery. JAMA (2013) 2.06
Formation of large coronary arteries by cardiac progenitor cells. Proc Natl Acad Sci U S A (2008) 2.05
Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res (2012) 2.02